# Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy

> **NCT03758963** · NA · COMPLETED · sponsor: **CynosureLutronic** · enrollment: 63 (actual)

## Conditions studied

- Central Serous Chorioretinopathy

## Interventions

- **DEVICE:** R:GEN Selective Retina Therapy

## Key facts

- **NCT ID:** NCT03758963
- **Lead sponsor:** CynosureLutronic
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-30
- **Primary completion:** 2018-04-02
- **Final completion:** 2018-06-20
- **Target enrollment:** 63 (ACTUAL)
- **Last updated:** 2018-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03758963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03758963, "Selective Retina Therapy With 'R:GEN' in Patients With Central Serous Chorioretinopathy". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03758963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*